A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Clinical trial NCT07206225 · RECRUITING

Trial details

NCT number: NCT07206225
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-muscle Invasive Bladder Cancer

Start date: 2025-11-06
Primary completion: 2030-01-29
Enrollment: 294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.